Introduction
Testicular cancer represents the most commonly diagnosed cancer in men younger than 35 . Its incidence in Europe is on the rise, doubling every two decades [1] . The highest rates of testicular cancer were noted for white Caucasian populations in industrialised countries, mostly in western and northern Europe and Australia/New Zealand [2] . Seminoma is the most common testicular tumour and is believed to arise from the seminiferous epithelium of the mature or maturing testis. Improvements in treatment of testicular cancer have resulted in prolonged survival and high cure rates. For patients with stage I seminoma in particular, regular surveillance, radiotherapy, and/ or carboplatin-based chemotherapy are viable options following an orchidectomy [3] . The prognosis for these patients is good, irrespective of the choice of treatment [4] . Radiotherapy is usually applied in patients with stage I, as adjuvant treatment following a radical inguinal orchidectomy, to minimize the potential relapse in the retroperitoneum and/or ipsilateral pelvis. Furthermore, in patients with stage IIA and IIB, where the regional lymph nodal metastasis is smaller than 5 cm, radiotherapy is given as a definitive therapeutic intervention. In stage IIC, where the regional node metastasis exceeds 5 cm, cisplatin-based combination chemotherapy is commonly used as the primary form of treatment [5] .
Here we report a case of a 34-year-old male patient with a stage IB seminoma relapsed in the pelvis two years after surgery and adjuvant radiotherapy. During the second cycle of bleomycin-etoposide-cisplatin (BEP) chemotherapy, he suffered a cerebral infarction. This case is particularly interesting from the clinical point of view because it describes a very rare cisplatin-related Abstract: We report a case of a testicular seminoma patient with relapse who was irradiated after acute cerebral infarction induced by cisplatin-based chemotherapy. Lymphocytic genome instability was studied using an alkaline comet assay, analysis of structural chromosome aberrations, and cytokinesis-block micronucleus assay in blood samples collected before and after PET CT scanning that preceded radiotherapy, as well as before the administration of the first and after the administration of the last fraction of 3D conformal radiation. A challengetest with hydrogen peroxide (H 2 O 2 ) was performed on isolated peripheral blood lymphocytes in order to establish to what extent earlier therapies had modified the response of the patient's DNA to external stimuli with a genotoxic chemical. Levels of primary DNA damage in lymphocytes increased after diagnostic exposure, lowered prior to administration of a conformal 3D radiotherapy, and were the highest at the end of radiotherapy. Ex vivo exposure to H 2 O 2 caused additional lymphocyte DNA damage, which gradually increased 15 and 30 minutes after treatment. Diagnostic and therapeutic exposure to radiation caused measurable cytogenetic damage that was subjected to extensive repair. All of the obtained results point to increased genomic instability in the patient which should be taken into account in his future medical surveillance.
side effect in a young male patient without comorbidities. After the patient recovered, it was decided to discontinue chemotherapy and proceed with the treatment of the seminoma relapse by applying radiotherapy on the right pelvic lymph nodes area. Considering the patient's medical history, we found this case interesting for the study of lymphocyte genome susceptibility, which was performed using standard DNA and cytogenetic biomarkers (alkaline comet assay, structural CA and CBMN assay). To our knowledge, similar studies have not been reported so far, and the obtained results might help to characterize and successfully manage future genetic risks for the patient studied and other similar cases.
Subject and methods

Case description
In April 2010, a 34-year-old male was diagnosed with a seminoma in his right testicle. He underwent a radical inguinal orchidectomy. The pathology was reviewed by a genitourinary pathologist, confirming a seminoma with positive rete testis, vascular invasion; tumour size was 8 cm, pT2N0M0S0, stage IB. A computed tomography (CT) scan of the chest, abdomen and pelvis was clear with no evidence of metastatic disease. He smoked 20 cigarettes a day for ten years (1999 to 2009). His grandmother had a cerebrovascular insult when she was 70 years old.
The patient was initially treated with adjuvant radiotherapy (2D) using two opposite Anterio-Posterior / Posterio-Anterior (AP-PA) fields applied to para aortic lymph nodes -from thoracic 11 (Th11) to lumbar 5 (L5) vertebrae ( Figure 1 ). The total radiation dose was 24 Gy divided into 16 fractions. After radiotherapy, the patient continued with normal life and regularly attended control examinations every 6 months. During the regular checkups, the values for full blood counts, AST, ALT, ALP, GGT, bilirubin, urea, creatinine, alpha-fetoprotein, lactate dehydrogenase, and beta-human chorionic gonadotropin were normal. Chest X-rays and the MR scans of the abdomen and pelvis showed no evidence of a relapse until June 2012.
In July, 2012 the patient was urgently hospitalized due to stomach pain. A CT scan of the abdomen and pelvis with angiography were performed. The CT scan revealed a hypodense mass 5 x 2.5 cm with a blur of the surrounding fat tissue and fattened peritoneum on the right side of the iliac blood vessels. The results of other tests were normal and the angiography showed normal blood vessels, aorta, and iliac arteries. A hypodense spindle structure with heterogeneous attenuation values 14-35HU near the right external iliac artery and vein next to medial edge musculus iliacus was observed. It was highly likely that the patient had a seminoma relapse into the right iliac lymph nodes from the field of radiation.
There was no history of a coagulation disorder or any cerebrovascular event and the patient started with BEP chemotherapy, consisting of bleomycin (30 units per 
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week on days 1, 8, and 15), etoposide (100 mg m -2 ), and cisplatin (20 mg m -2 ), repeat every 21 days [3] . During the second cycle (out of the four planned), in September 2012, the patient developed an acute cerebral infarction and chemotherapy was discontinued.
The patient was immediately transferred to a neurology clinic. The Multislice computed tomography (MSCT) could not exclude a vasogenic oedema. A hypodense zone of unknown etiology in the left basal ganglia area of the brain was observed. The patient underwent an MR scan with a sagittal, transversal, and frontal section of the brain. The scan showed a cortical triangular zone hyperintensive on T2 and FLAIR measured scans in the area of the boundary vascular segment of the left medial cerebral artery and left posterior cerebral artery. In the described area, a restricted diffusion associated with acute ischemia was identified. After the application of contrast media, no post contrast inhibition in the brain parenchyma was spotted. The position and size of ventricular system was normal without any signs of a hypertensive hydrocephalus. A scan of the optic chiasm, pontocerebellar angle, and cavernous sinuses revealed a normal morphological structure. A chest X-ray showed a normal intrathoracal status. The Transcranial Doppler (TCD) registered a normal flow in all blood vessels of the VB drain. Color Doppler flow imaging (CDFI) of the carotids showed a morphologically thickened arterial wall in the neck segment of the carotids with multiple arterial plaques in both of the carotid bifurcations without signs of significant stenosis. A Doppler ultrasound showed normal flow. The patient had also undergone a TCD to detect possible patent foramen ovale (PFO). He was injected with 9 mL of saline solution and 1 mL of air with a programme to detect high intensity transient signals (HITS). It came out positive for RL shunt, most likely PFO.
The patient was treated at the neurology clinic and made an almost complete recovery.
After the patient recovered, the decision was made to start with radiotherapy. To evaluate the status of the patient before radiotherapy in November 2012, positron emission tomographic (PET)/computed tomographic (CT) scanning with 18 F-fluorodeoxyglucose (activity 111.6 MBq; SUV max 6.1) was performed. After that, the patient was treated with three-dimensional conformal radiotherapy (3D-CRT). It consisted of 40 Gy in 20 fractions and was applied to the right side of the pelvis (Figure 2 ). Since the patient completed radiotherapy (in December 2012), he has remained free of relapse.
Considering the above mentioned medical history of the patient, which included radiotherapy in 2010 and two cycles of cisplatin-based chemotherapy in 2012, we found his case interesting for the study of lymphocyte genome susceptibility. The patient was informed on the aim and possible outcomes of the study and gave his consent to participate in blood samplings. Venous blood (10 mL per sampling) was collected in sterile heparinised vacutainers (Becton Dickinson, USA) containing lithium heparin as the anticoagulant and immediately transferred into the cytogenetic laboratory.
Altogether four blood samples were collected: (I) prior to the PET CT scan; (II) after the PET CT scan; (III) before administration of the first fraction of conformal radiation; (IV) after administration of the last fraction of conformal radiation. 
The alkaline comet assay
The alkaline comet assay was performed according to Singh et al. [6] , with minor modifications. A detailed description of the sample preparation was given in our previous paper [7] . Two agarose "sandwich" microgels per sample were prepared. The slides were analysed blindly by a single observer using an image analysis system (Comet Assay IV, Perceptive Instruments Ltd., U.K.) connected to a fluorescence microscope (Olympus BX, Japan; 200x magnification) equipped with appropriate filters. Altogether 100 comets (50 per each replicate slide) were measured. They were randomly captured at a constant depth of the gel, avoiding the edges of the gel, superimposed comets, dead cells, and cells near or in trapped air bubbles. The parameters selected for the quantification of DNA damage were: mean comet tail length, tail intensity (DNA % in the tail), and tail moment as calculated by the software.
Challenge-test with hydrogen peroxide on isolated peripheral blood lymphocytes
To establish whether earlier therapies modified the response of patient's DNA to external stimuli with a genotoxic chemical, we performed a simple challengetest with hydrogen peroxide (H 2 O 2 ) on isolated peripheral blood lymphocytes (PBL) by measuring the levels of baseline and H 2 O 2 -induced DNA damage using the alkaline comet assay.
Lymphocytes were isolated using the Histopaque ® -1077 reagent (Sigma-Aldrich, USA), according to the manufacturer's instructions [8] . Isolated PBLs were placed in sterile Falcon tubes in a RPMI-1640 culture medium (Gibco, Invitrogen, USA) and their viability was checked using an acridine orange / ethidium bromide in situ fluorescent assay [9] . Fluorescent dyes (Sigma-Aldrich, USA) were mixed with cell suspension in final concentrations of 100 µg mL -1 (1:1; v/v). Three parallel probes with aliquots of the same sample were performed. A total of 300 cells per sample were scored on epifluorescence microscope (Olympus BX, Japan; 400x magnification) to determine the percentage of viable, apoptotic and necrotic cells.
Using freshly isolated PBL, two microgels for the alkaline comet assay which served as controls were prepared. The remaining PBL were then treated ex vivo with H 2 O 2 (Merck, Germany) as proposed by Sham et al. [10] . The PBL were incubated in 45 mmol L -1 of H 2 O 2 in PBS (pH 7.4) for 5 min on ice. Immediately after treatment, two microgels were prepared once more. The remaining cell solution was washed with cold PBS and centrifuged. Then RPMI 1640 medium supplemented with 10 % fetal bovine serum (Gibco, Invitrogen, USA) was added to the cells and they were incubated at 37 °C for a further 120 minutes. To evaluate the efficiency of DNA repair, microgels were also prepared after 15, 30, 60, and 120 minutes of incubation. They were further processed according to standard comet assay procedure.
Analysis of structural chromosome aberrations (CA)
The analysis of structural CA was performed following recommendations by the International Atomic Energy Agency [11] . Two lymphocyte cultures were established for each blood sample. The slides were stained with a 5% Giemsa solution (Merck, Germany) and analysed blindly by a light microscope at 1000x magnification under oil immersion. A total of 200 metaphases were examined for total number and type of aberrations, as well as the proportion of aberrant cells.
Cytokinesis-Blocked Micronucleus (CBMN) Assay
Lymphocyte cultures were incubated for 72 h in line with the standard protocol for the CBMN assay [12] . Cytochalasin B (Sigma-Aldrich, USA) at a final concentration of 6 μg mL -1 was added to the culture at the 44 th hour. Micronuclei (MN) counting was performed by a light microscope at 1000x magnification under oil immersion. The identification of MN, nuclear buds (NB), nucleoplasmic bridges (NPB), and apoptotic (A) and necrotic (N) cells was done according to the criteria by Fenech et al. [13] . A total of 1000 binucleated (BN) cells per each blood sample was examined. The same slides were used to study the nuclear division index (NDI), by counting 1000 cells per sample. NDI was computed by the formula: NDI = (M 1 + 2M 2 + 3M 3 + 4M 4 )/N, where M 1 -M 4 represents the number of cells with 1-4 nuclei, respectively, and N the number of cells scored [14] .
Statistical analysis
For the statistical evaluations we used the commercial programme Statistica 12.0 software (StatSoft, Tulsa, USA). The level of DNA damage, as estimated by the alkaline comet assay, was evaluated using standard descriptive statistics; mean ± standard error of the mean, median and range of the comet parameters measured were analysed. The comparisons between samples were done using one-way analysis of variance (ANOVA) on logarithmically transformed data. Subsequently, the post-hoc Scheffé test was used for calculations concerning pair-wise comparisons. Comparisons among the values obtained for cell viability, apoptosis, and necrosis were made by Pearson's χ 2 -test for two-by-two contingency tables. This test was also applied for the statistical evaluation of data regarding the structural chromosome aberrations in PBL, CBMN assay, and lymphocyte proliferation kinetics. Statistical decisions were made at a significance level of p < 0.05.
Results
The alkaline comet assay
The results of alkaline comet assay are summarized in Table 1 . Photomicrographs of leukocyte nuclei observed after the alkaline comet assay procedure are shown in Figure 3 . Levels of primary DNA damage increased after diagnostic exposure to PET CT procedure, lowered prior to administration of a conformal 3D radiotherapy, and Legend: I-IV represent blood samplings: (I) prior to the PET CT scan; (II) after the PET CT scan; (III) before administration of first fraction of conformal radiation; (IV) after administration of the last fraction of conformal radiation. Parameters of the alkaline comet assay were estimated in 100 comets (50 comets per each slide were measured). increased again in the course of radiotherapy, being the most pronounced in the fourth blood sample collected at the end of radiotherapy. Statistically significant differences in the levels of primary DNA damage among four blood samples are highlighted in Table 1 .
Challenge-test with hydrogen peroxide on isolated peripheral blood lymphocytes
Using acridine orange / ethidium bromide in situ fluorescent assay in the first blood sample we recorded 81.7±1. 
The analysis of structural CA
In the first blood sample we scored 6.0% of aberrant metaphases (Table 3) , and their number gradually increased both after diagnostic examination by PET CT and radiotherapy. In blood samples collected after diagnostic and therapeutic irradiation (II-IV), the number of cells containing more than 1 CA increased. Microscopic analysis revealed several aberration types, but the most prominent were acentric fragments. The number of dicentric, polycentric, and ring chromosomes increased both after diagnostic examination and radiotherapy (Table 3) . However, no statistically significant differences between blood samplings were observed. A photomicrograph of aberrant metaphase with dicentric and acentric chromosomes is shown in Figure 4 . 
CBMN assay
The results of the CBMN assay are reported in Table  4 . The number of micronucleated cells per 1000 cells in the first blood sample was 25. Diagnostic exposure caused a slight, but non-significant increase in the number of micronucleated cells and MN. The incidence of micronucleated cells slightly decreased in samples III and IV. However, the total number of MN in those samples increased, principally due to the presence of micronucleated cells that contained more than one MN. Diagnostic and therapeutic exposure to radiation also induced the formation of nuclear buds (NB) and nucleoplasmic bridges (NPB). Their frequencies were the highest in the third blood sample (Table 4) . Similar trends were observed for the frequencies of lymphocytes in apoptosis and necrosis. Necrosis as type of cell death slightly dominated over apoptosis. A gradual decrease of NDI values after diagnostic and therapeutic exposure to radiation was observed and confirmed by statistical analysis, the results of which are highlighted in Table  4 . Figure 5 shows the photomicrographs of, a binuclear lymphocyte with NPB, a binuclear lymphocyte with two MN and a binuclear lymphocyte in apoptosis.
Discussion
Between 15% and 20% of seminoma patients with stage I relapse during the follow-up period if they do not receive adjuvant radiation therapy or carboplatin chemotherapy after an orchidectomy [15] . The patient presented here initially underwent surgery and adjuvant radiotherapy. He was one of the 141 patients diagnosed with stage I seminoma and treated by adjuvant radiotherapy during a 8-year period (2003-2011) at our Clinic. The median follow-up period of this group was 6.5 years. Six patients (4%) experienced a relapse (5 in the ipsilateral pelvic nodes, 1 in the mediastinal lymph nodes). The period with the highest risk of a relapse was estimated at 6 to 25 months after the orchidectomy [16] .
In the case presented here, a relapse was observed within two years after initial treatment. Since the relapse was localized in the right iliac lymph nodes outside the field of radiation, a possible reason for this condition could be the use of two-dimensional radiotherapy (2D-RT). In previous studies [17, 18] , marginal misses were reported in patients with stage I testicular seminoma treated with AP-PA fields based on their bony anatomy. The same method was applied in our patient. Legend: I-IV represent blood samplings: (I) prior to the PET CT scan; (II) after the PET CT scan; (III) before administration of first fraction of conformal radiation; (IV) after administration of the last fraction of conformal radiation. * Percentage is calculated with respect to the total number of CA The management approach for recurrent seminoma that relapsed within 2 years usually involves chemotherapy, mainly using a cisplatin-based protocol like BEP [1] . In the case of our patient, the same treatment was applied; however, during the second cycle, he suffered an acute cerebral infarction. Although the patient received a multidrug protocol, the main cause for the above described clinical symptoms could be cisplatin, for which serious vascular side effects and cerebrovascular complications were often reported in the past. According to Gerl [19] , the frequency of cerebrovascular complications after administration of cisplatin-based chemotherapy is estimated to be less than 1 in 2000 treated patients. Several studies reported both cerebrovascular and cardiovascular complications and thromboembolic events in testicular seminoma patients receiving cisplatin-based chemotherapy [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . Since cisplatin can also cause acute and delayed CNS toxicity [30] oncologists should be aware of the possible adverse effects of cisplatin-based protocols.
An important issue in the survivors of testicular seminoma are the late effects of the treatment. They are usually divided into conditions that threaten the patients' lives or health (secondary malignancies, cardiovascular disease) and conditions that diminish quality of life (weakness, infertility). Growing awareness regarding these potential morbidities has resulted in risk-adapted treatment strategies aimed at reducing treatment-related toxicity while retaining efficacy [31] . One of the most important strategies includes reductions of the radiation dose and field in the treatment of seminoma.
In the case described here, due to the severe cerebrovascular complications that occurred in the course of chemotherapy, it was decided that the patient should proceed with radiotherapy. To achieve the best results and reduce the radiation dose, we used three dimensional conformal radiotherapy (3D-CRT) based on vascular and nodal anatomy on computed tomography (CT) scans. This approach is much better than 2D-RT, which was employed on the same patient as a treatment modality in 2010, when he was initially treated after surgery. A previous report [32] suggested that 3D-CRT significantly lowered the risk of a second cancer arising in the kidneys, liver, or bowel in comparison to intensity-modulated radiotherapy.
A second cancer represents the worst possible longterm complication of therapy for testicular cancer, often leading to death in patients cured of their primary malignancy. Risks of secondary solid tumours can mainly be attributed to radiotherapy, while secondary leukaemia is primarily associated with chemotherapy [33] . However, since the overall frequency of secondary cancers observed among the survivors was rather low, the risk for the patient in question to develop one appears small.
Various molecular biology and cytogenetic biomarkers can be used to estimate individual genome sensitivity and predict individual cancer risk [34] [35] [36] [37] [38] , which is especially important in survivors cured of their primary malignancy. These methods usually involve peripheral blood lymphocytes, which have been established as suitable biodosimeters because of their easy accessibility, synchronous population, low incidence of spontaneous chromosomal aberrations, suitable culture methods, and simplicity of sample collection [39] [40] . The levels of DNA/ chromosome damage measured in lymphocytes might reflect the levels of damage produced by cancer therapy in other non-target cells or tissues. As it is known, approx. 80% of human lymphocytes belong to the redistributional pool, which means that if those that contain chromosome aberrations are induced to the human body, they will undoubtedly appear in peripheral blood [10] . Two shortterm assays are most frequently used in estimating DNA damage: analysis of structural chromosome aberrations (CA) and cytokinesis-block micronucleus (CBMN) assay. However, in the last decade, the significance of comet assay or single cell gel electrophoresis, a method that enables a direct assessment of primary DNA damage, has also increased in human biomonitoring studies [41] [42] [43] [44] . The same methods were used in the present study to assess DNA and cytogenetic damage in the PBL of a patient with testicular seminoma.
Previous studies on cancer patients [45] [46] [47] indicate that they often had genomic instability in PBL, even before the administration of any kind of treatment modality. Spontaneous genomic instability observed in ex vivo dividing lymphocytes could be primarily related to the genetic make-up of an individual. High frequencies of certain types of structural CA and MN are the consequence of intracellular deficiencies in DNA replication, defects in DNA repair, defects in the mitotic spindle, kinetochore apparatus or centrosome, defects in cell cycle arrest or of the diminished capacity of cells to endure apoptosis [45] . Both chemotherapy and radiotherapy significantly contribute to induced genomic instability by causing delayed genetic damage which results in a persistently elevated frequency of de novo mutations, chromosomal aberrations or lethality in significant fractions of the progeny cell population [48, 49] .
Considering that our patient had a 10-year smoking history and that he was previously treated with radiotherapy, as well as that he received two cycles of BEP chemotherapy two months prior to this study, it did not come as a surprise that the initial levels of DNA damage (as measured by the alkaline comet assay) and chromosome damage (recorded by the CA analysis and CBMN assay) in the first blood sample displayed increased values with respect to the normal background values for Croatian male subjects of the same age [50] [51] [52] . In contrast, such increased levels of DNA and chromosome damage were quite comparable to values previously recorded in other patients with testicular seminoma [7, 53, 54] .
The BEP protocol that was administered to our patient consists of three antineoplastic drugs capable of inducing DNA/chromosome damage and cytotoxicity. Cisplatin acts like a bifunctional alkylating agent, resulting in inter-and intrastrand DNA crosslinking [30] . Bleomycin caused mainly single-and double-strand breaks by creating a complex with ferrous ions and molecular oxygen, resulting in the release of oxygen radicals at the site of DNA intercalation [55] . Etoposide is also capable of producing multiple double-strand breaks within chromatin [56] . Their genotoxic potentials towards the PBL of cancer patients have been recognized as far back in history as the 1990s [57] [58] [59] , and confirmed later on in many other studies [60] [61] [62] [63] .
To establish the extent to which earlier therapies modified the response of patient's DNA to external stimuli with a genotoxic chemical, a simple challenge-test with H 2 O 2 on PBL isolated from the first blood sample was performed. Previous studies [10, 64, 65] have established that H 2 O 2 can induce a concentration-dependent increase in DNA strand breakage in human leukocytes, both in healthy subjects and in cancer patients. The principal mechanism of H 2 O 2 -induced damage is the production of the hydroxyl radical close to a DNA molecule through the Fenton reaction [66] . It is interesting to stress that following isolation and before treatment of PBL with H 2 O 2 , we found a relatively high percentage of apoptotic cells (17.7±2.3 %). The increased values of all comet assay parameters measured after treatment indicated that PBL were very sensitive to H 2 O 2 and that evidence leads us to conclude that the integrity of the patient's DNA was highly impaired, obviously due to previous therapeutic interventions. Since no data about the patient's background genome damage (before he was diagnosed with testicular cancer in 2010) was available, we cannot estimate whether his original genetic make-up reflected any inherited genome instability. However, such a high response in terms of significantly increased primary DNA damage after a challenge with relatively low concentration of H 2 O 2 could be reason for concern in the future surveillance of this patient, as it is well-known that increased genomic instability is an important risk factor in the development of second cancers [49] .
The aim of the second blood sampling was to establish whether and how diagnostic exposure (PET CT scan) affects the lymphocyte genome integrity in our patient. Positron emission tomography (PET) and PET/computed tomography (CT) are essential techniques in oncologic imaging. Their biggest advantage is that a single wholebody examination can provide an accurate assessment of disease activity and spread, which is extremely important in accurate staging, therapy response assessment, and early detection of recurrent disease [67] . However, PET/ CT scanning is accompanied by a substantial radiation dose. For instance, a study on whole-body PET/CT with 18 F-fluorodeoxyglucose ( 18 F-FDG; activity 370 MBq), which evaluated three different CT protocols in male patients [68] , revealed doses of 13.65, 24.80, and 32.18 mSv, depending on the protocol applied. The authors estimated that the associated lifetime cancer incidence for patients around 20 years of age was up to 0.514% for the U.S. population and up to 0.622% for the Hong Kong population. In the case described here, the patient was also subjected to 18 F-FDG PET/CT scanning, prior to administration of conformal 3D radiotherapy. Results of all of the analyses performed on the second blood sample taken after 18 F-FDG PET/CT scanning indicated an increase of DNA/ chromosome damage in PBL as compared to initial values. Primary DNA damage was especially pronounced: mean tail DNA % increased from 1.58±0.33 to 4.99±0.77, which was considered highly significant. Although the total number of structural CA remained the same as in the earlier sampling, the number of MN increased due to the presence of micronucleated cells that contained more than one MN. The observed increase of DNA/chromosome damage could be obviously attributed to the absorption of radiation from the diagnostic procedure, in which the 18 F-FDG activity was 111.6 MBq.
Results of the alkaline comet assay on the third blood sample taken 17 days after PET CT scanning and after the first fraction of conformal radiation was administered showed that primary DNA damage significantly decreased. The number of structural chromosome aberrations slightly increased, while the number of MN was similar to the second blood sampling. The findings of lower primary DNA damage and an increased frequency of CA suggest that, during the 17 days between the second and third blood sampling, DNA repair systems tend to diminish the DNA damage caused by diagnostic exposure. The same was observed in the patients with testicular cancer involved in our previous study [7] .
In the fourth blood sample taken after administration of the last fraction of conformal radiation, we once again found increased levels of primary DNA damage, high frequency of CA, and a relatively high number of micronuclei. We should stress that both the types and frequencies of structural CA observed in that blood sample clearly reflected the exposure to ionizing radiation. As it is known, ionizing radiation induces various types of DNA damage both directly (base modifications, apurinic or apyrimidinic sites, breaking of hydrogen bonds between two helices, single-and double-strand breaks, cross linking) and indirectly through the generation of reactive oxygen species [69, 70] . The majority of radiation effects in radiotherapy are mediated by free radicals. Due to the non-uniform deposition of ionizing radiation energy, clusters of lesions or multiply damaged sites also formed, which significantly contributed to the lethality of ionizing radiation [56] . DNA double strand breaks induced by ionizing radiation are the most important type of lesions responsible for the cytotoxic effects of radiation. If nonor misrepaired, they lead to chromosomal aberrations [71] . Some types of chromosome aberrations, particularly dicentrics and acentric fragments are responsible for the formation of MN and NPB [72] . The results of our study confirmed positive correlations between the above mentioned aberrations and outcomes of the CBMN assay.
MN frequencies are determined by the balance between the extent of cytogenetic damage and cell death and the associated induction of proliferative responses in normal cell precursors [58] . Their decline may be the result of the repair of induced lesions, replacement of damaged lymphocytes from a pool of imbalanced precursors or a combination of these processes [59] . Our results indicate that, after receiving the last fraction of radiation, the patient had high frequencies of micronuclei. However, earlier studies on other patients with testicular seminoma [7] have suggested that the frequencies of MN in the majority of patients returned to lower values six month and one year after cessation of therapy.
In the course of this study we also observed that the nuclear division index (NDI), which was studied concomitantly on microscopic slides for CBMN assay, steadily decreased. A similar phenomenon was observed in a related study on cancer patients by Jianlin et al. [73] . This finding suggests that both diagnostic and therapeutic exposure to ionizing radiation causes delays in lymphocyte cell cycle. As it is known, these delays allow the cell to repair DNA through attempts to reduce the adverse effects of radiation [74] .
Taken together, the results of the present study showed that radiotherapy increased the levels of primary DNA-and chromosomal damage in the peripheral blood lymphocytes of our patient. We are aware that the present study is limited with only one case reported. However, its introductory nature will be extended in future research that will focus on a larger group of patients diagnosed with the same or similar malignancy.
Nevertheless, our findings confirm the reports of previous studies on the effects of radio-or chemotherapy on non-target cells in cancer patients [7, 46, [57] [58] [59] [60] [61] [62] .
Although radiotherapy has improved prognosis in cancer patients, its late delayed effects are a matter for concern. Even though the majority of lesions induced by ionizing radiation are efficiently repaired in a relatively short time after exposure [71, [75] [76] [77] , part of the DNA damage still remains unrepaired and may result in DNA and RNA mutations, which in turn may lead to the onset of a second cancer [56] .
The timely detection of high risk individuals may provide arguments for more stringent surveillance and prevention in the management of many various cancers. Based on our findings, the use of short-term assays on non-target cells, such as lymphocytes, could be valuable, especially in cases where the life expectancy in the survivors is high, as is the case with testicular seminoma.
